(411 days)
Not Found
No
The device description and performance studies focus on the mechanical and material properties of a physical connector, with no mention of software, algorithms, or data processing related to AI/ML.
No.
The device is described as a connector designed for drug administration to an I.V. bag without using a sharp hypodermic needle. Its purpose is to facilitate the safe addition of drugs to an IV bag, not to directly treat or diagnose a disease.
No
The device is designed for drug administration, providing a safe way to add drugs to an IV bag. It does not perform any diagnostic function.
No
The device description and performance studies clearly indicate a physical medical device (a safety connector with a shielded needle) and include extensive testing related to hardware components and materials. There is no mention of software as a component of this device.
Based on the provided information, the SOL-CARE IV Bag Safety Connector is not an In Vitro Diagnostic (IVD) device.
Here's why:
- Intended Use: The intended use is for "drug administration to I.V. bag without using sharp hypodermic needle attached to a drug pre-filled syringe." This describes a device used for administering substances into the body (via an IV bag), not for examining specimens from the body to provide diagnostic information.
- Device Description: The description reinforces its function in accessing an IV bag for drug addition, not for analyzing biological samples.
- Lack of IVD Characteristics: The document does not mention any of the typical characteristics of an IVD, such as:
- Analyzing biological specimens (blood, urine, tissue, etc.)
- Providing diagnostic, monitoring, or screening information
- Using reagents or assays
- Measuring analytes
The device is clearly designed for a procedural function related to drug delivery, which falls outside the scope of In Vitro Diagnostics.
N/A
Intended Use / Indications for Use
The SOL-CARE IV Bag Safety Connector is designed for drug administration to I.V. bag without using sharp hypodermic needle attached to a drug pre-filled syringe. It incorporates a shielded needle to allow safe access through the injection port of I.V. bag.
Product codes
LHI
Device Description
The device provides a simple, cost-effective solution to an everyday problem - how to make drug additions to an IV bag without using an exposed hypodermic needle attached to a drug-filled syringe. It incorporates a shielded needle to allow safe access through the 'rubber bung' on the INJECTION tail of an IV bag.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies
The SOL-CARE IV Bag Safety Connector met the appropriate requirements contained in the following standards:
- EN ISO 7864:2016, Sterile hypodermic needles for single use-Requirements and test methods.
- EN ISO 80369-7:2016, Small-bore connectors for liquids and gases in healthcare applications - Parts for intravascular or hypodermic applications.
- EN ISO 9626:2016, Stainless Steel needle tubing for the manufacture of medical devices - Requirements and test methods
- ISO 11607-1-2:2017, Packaging for terminally sterilized medical devices, Parts 1 and 2.
- ISO 11135:2014, Sterilization of health care products Ethylene oxide - Requirements for development, validation and routine control of a sterilization process for medical devices.
- ISO 10993-1:2018, Biological evaluation of medical devices Part 1: Evaluation and testing
Summary of Testing: The tests below are according to ISO 7864 except as indicated with the relevant standard adjacent to the testing name.
- Cleanliness
- Defects of Needle
- Defects of needle point
- Lubricant
- Needle Gauge
- Needle Stiffness
- Needle Resistance to Breakage
- Bond Between Needle hub and Needle
- Patency of Lumen
- Distance from Needle tip to Protector Tube
- Connection Strength Between Protection tube and Needle Hub
- Penetration Force
- Luer connection testing per ISO 80369-7 and ISO 80369-20
- Flow Rate
- Priming Volume
- Particulate Contamination (ISO 8536-4:2019)
- Limits for acidity or alkalinity (For Needle)
- Limits of Extractable Metals (For Needle)
- Needle Resistance to Corrosion ISO 9626:2016
- Reducing Substance ISO 8536-4:2010
- Metal Ions ISO 8536-4:2010
- Titration Acidity or Alkalinity ISO 8536-4:2010
- Residue on Evaporation ISO 8536-4:2010
- UV Absorption of extract Solution ISO 8536-4:2010
Sterilization and Packaging Test according to ISO 11607
- Sterilization (EO/ECH residue) ISO 10993-7 :2008
- Appearance (visual check)
- Dimension (dimensional measurement)
- Printing (visual check)
- Tearing Force
- Clean Peel
- Dye Penetration
- UDI Identification
- Sticker readability and integrity (Visual)
Biological Test according ISO 10093
- Cytotoxicity (Tested to ISO 10993-5:2009)
- Sensitization (Tested to ISO 10993-10:2010)
- Irritation of Intracutaneous Reactivity (Tested to ISO 10993-10:2010)
- Acute Systemic Toxicity (Tested to ISO 10993-11:2006)
- Material Mediated Pyrogenicity (Tested to ISO 10993-11:2006)
- Hemocompatibility (ISO 10993-4:2017)
- Partial Thromboplastin (PTT) ISO 10993-4:2017
- Platelet Count ISO 10993-4:2017
- Haematology ISO 10993-4:2017
Key results: Performance testing demonstrated that the differences in length do not raise any questions of safety and effectiveness. The biocompatibility and performance testing shows that differences in materials of construction do not raise any questions of safety or effectiveness. The differences between the predicate and the subject device do not raise any new or different questions of safety or effectiveness.
Key Metrics
Not Found
Predicate Device(s)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 880.5440 Intravascular administration set.
(a)
Identification. An intravascular administration set is a device used to administer fluids from a container to a patient's vascular system through a needle or catheter inserted into a vein. The device may include the needle or catheter, tubing, a flow regulator, a drip chamber, an infusion line filter, an I.V. set stopcock, fluid delivery tubing, connectors between parts of the set, a side tube with a cap to serve as an injection site, and a hollow spike to penetrate and connect the tubing to an I.V. bag or other infusion fluid container.(b)
Classification. Class II (special controls). The special control for pharmacy compounding systems within this classification is the FDA guidance document entitled “Class II Special Controls Guidance Document: Pharmacy Compounding Systems; Final Guidance for Industry and FDA Reviewers.” Pharmacy compounding systems classified within the intravascular administration set are exempt from the premarket notification procedures in subpart E of this part and subject to the limitations in § 880.9.
0
Image /page/0/Picture/0 description: The image contains the logo of the U.S. Food and Drug Administration (FDA). The logo consists of two parts: the symbol of the Department of Health & Human Services on the left and the FDA acronym along with the full name of the agency on the right. The FDA part of the logo is in blue, with the acronym in a square and the full name written out next to it.
November 3, 2021
Sol-Millennium Medical Group Jim Barley Director RA 315 Shawnee North Drive. Suite 100 Suwanne, Georgia 30024
Re: K202732
Trade/Device Name: SOL-CARE IV Bag Safety Connector Regulation Number: 21 CFR 880.5440 Regulation Name: Intravascular Administration Set Regulatory Class: Class II Product Code: LHI Dated: October 7, 2021 Received: October 8, 2021
Dear Jim Barley:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part
1
801); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4. Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.
For comprehensive regulatory information about mediation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).
Sincerely,
For Payal Patel Assistant Director DHT3C: Division of Drug Delivery and General Hospital Devices, and Human Factors OHT3: Office of GastroRenal, ObGyn, General Hospital and Urology Devices Office of Product Evaluation and Quality Center for Devices and Radiological Health
Enclosure
2
Indications for Use
510(k) Number (if known) K202732
Device Name SOL-CARE IV Bag Safety Connector
Indications for Use (Describe)
The SOL-CARE IV Bag Safety Connector is designed for drug administration to I.V. bag without using sharp hypodermic needle attached to a drug pre-filled syringe. It incorporates a shielded needle to allow safe access through the injection port of I.V. bag.
| Type of Use (Select one or both, as applicable) |
|---|
| ------------------------------------------------- |
| ☒ Executive Use (Under 49 CFR 229.14(a) and (b)) | ☐ Day-to-Day Operations (Under 49 CFR 229.14(c)) |
|---|---|
| -------------------------------------------------------------------------------------------------- | -------------------------------------------------- |
X Prescription Use (Part 21 CFR 801 Subpart D)
__ Over-The-Counter Use (21 CFR 801 Subpart C)
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
3
Image /page/3/Picture/0 description: The image contains the logo for SOL-MILLENNIUM. The logo features an orange abstract design on the left, followed by the text "SOL-MILLENNIUM" in black. Below the text, there is a tagline in a cursive font that reads "Building a healthier tomorrow".
510(k) Summary K202732
Date Prepared: November 2, 2021
- A. Submitter Information Sol-Millennium Medical, Inc. 315 Shawnee North Drive, Suite 100 Suwanee, GA 30024 Phone Number: 414-238-5673
| Primary Contact Person: | PJ Pasia
Director, Regulatory Affairs
847-363-1264
ppasia@sol-m.com |
| ------------------------- | ------------------------------------------------------------------------------ |
|---|
Secondary Contact Person: James Barley Director of RA (404) 433-3058 jbarley@sol-m.com
B. Device Information
- Trade or Proprietary Name: SOL-CARE IV Bag Safety Connector ●
- Common Name: I.V. Fluid Transfer Set ●
- Regulation Name: Intravascular administration set
- Regulation Number: 21 CFR 880.5440 ●
- Classification: Class II
- Establishment Registration Number 3014312726 ●
- Panel: General Hospital ●
- . Product codes: LHI
C. Predicate device
- Predicate: K083851 Inviro Medical Blunt fill Needle ..
D. Device Description
SOL-CARE IV Bag Safety Connector HYP001
The device provides a simple, cost-effective solution to an everyday problem - how to make drug additions to an IV bag without using an exposed hypodermic needle attached to a drug-filled syringe. It incorporates a shielded needle to allow safe access through the 'rubber bung' on the INJECTION tail of an IV bag.
4
Image /page/4/Picture/0 description: The image shows the logo for SOL-MILLENNIUM. The logo features an orange abstract design on the left, followed by the text "SOL-MILLENNIUM" in black. Below the text, there is a tagline in a cursive font that reads "Building a healthier tomorrow".
Catalog Number
Following is a listing of model numbers and product descriptions included in thissubmission:
| Sol-Care Hypotec REF Catalog Numbers and
| Description | |
|---|---|
| REF/Catalog # | Description |
| HYP001 | SOL-CARE IV Bag Safety Connector |
- E. Statement of Indications for Use
SOL-CARE IV Bag Safety Connector (HYP001)
The SOL-CARE IV Bag Safety Connector is designed for drug administration to I.V. bag without using sharp hypodermic needle attached to a drug pre-filled syringe. It incorporates a shielded needle to allow safe access through the injection port of I.V. bag.
- F. Comparison of Technological Characteristics: The SOL-CARE IV Bag Safety Connector is substantially equivalent to the InviroMedical Blunt Fill Needle.
The following table compares the physical, mechanical, biological and chemical specifications of the SOL-CARE IV Bag Safety Connector to the Inviro Medical Blunt Fill Needle.
| ELEMENT OF
COMPARISON | Inviro Medical Blunt
Fill
Needle (Predicate
Device) | SOL-CARE IV Bag Safety
Connector | Comments |
|------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-----------|
| Classification
Name | Set, I.V. Fluid Transfer | Intravascular Administration
Set | SE |
| Product Code | LHI | LHI | SE |
| 510(k) # | K083851 | K202732 | N/A |
| Regulation
Number | 21CFR 880.5440 | 21CFR 880.5440 | SE |
| Indications For
Use | The Inviro Blunt and
Inviro Blunt w/EZ
Wings Cannulas are
used in conjunction
with a syringe as an
additive device for
aspiration from multi-
dose medicine vials or
injection into I.V.
Systems and pre. | The SOL-CARE IV Bag
Safety Connector is designed
for drug administration to I.V.
bag without using sharp
hypodermic needle attached to
a drug pre-filled syringe. It
incorporates a shielded needle
to allow safe access through the
injection port of I.V. bag. | SE |
| | slit septums covering
injection sites. | | |
| principle of
operation | Facilitate the transfer of
medication from the
medicine vial into a
syringe, then inject the
medication into an I.V.
System. | Facilitate the transfer of
medication from the syringe
into the I.V. System. | SE |
| needle length | 1-1/2" | 1-1/2" and 2" | Different |
| needle gauge | 18 gauge | 18 gauge | SE |
| needle tip
configuration | Blunt - 45 degree tip
angle | Blunt - 45 degree tip angle | SE |
| lubricant | Silicone oil | Silicone oil | SE |
| reuse durability | No | No | SE |
| hub/needle
bond strength | Per ISO 7886 | Per ISO 7886 | SE |
| Needle enclosed
within Tube
Holder | No | Yes | Different |
| biocompatibility | Per ISO 10993-1 | Per ISO 10993-1 | SE |
| Sterile | Yes | Yes | SE |
| Packaging | Silicone oil | Silicone oil | SE |
| materials | Needle Hub-
Polypropylene, Needle
– SUS 304, Glue –
Epoxy and Cap - ABS | Needle Hub-Polypropylene,
Needle – SUS 304, Glue –
Epoxy, Tube Holder -
Polypropylene | Different |
| labeling | Per 21 CFR 801 | Per 21 CFR 801 | SE |
5
Image /page/5/Picture/0 description: The image shows the logo for SOL-MILLENNIUM. The logo features an orange abstract design on the left, followed by the text "SOL-MILLENNIUM" in black. Below the text, there is a tagline in gray that reads "Building a healthier tomorrow". The logo also includes a registered trademark symbol.
Discussion
The main differences between the SOL-CARE IV Bag Safety Connector and the predicate device, Inviro Medical Blunt Fill Needle include:
6
Image /page/6/Picture/0 description: The image shows the logo for SOL-MILLENNIUM. The logo features an orange infinity symbol on the left. To the right of the symbol is the company name, "SOL-MILLENNIUM," in black, sans-serif font. Below the company name is the tagline "Building a healthier tomorrow" in a light gray, cursive font.
-
- Indications for Use - The intended use of the SOL-CARE IV Bag Safety Connector is to inject medication into an I.V. Bag while the intended use of the Inviro Medical Blunt Fill Needle is to transfer medication from the medicine vial into a syringe and then inject that medication into a I.V. Bag. The indications for use of the proposed device are a subset compared to the predicate device indications for use. Both devices are used by the same type of healthcare professionals under the same conditions of use. Both devices have an identical principle of operation as well as mechanism of action. The differences in wording in the indications for use statements do not introduce new questions regarding safety or effectiveness due to their similarities in purpose, function and conditions of use.
-
- Length of needle - The length of the Inviro Medical Blunt Fill Needle is 1.5 inches while the needle lengths for the SOL-CARE IV Bag Safety Connector are 1.5'' and 2''. The summary of testing below using FDA recognized standards shows additional tests conducted to address the differences in length of the needle. Performance testing demonstrated that the differences in length do not raise any questions of safety and effectiveness.
-
- Needle enclosed within a Tube Holder - The Sol-Care I.V. Bag Connector has the BluntFill Needle enclosed within a Tube Holder while the Blunt Fill Needle alone does not have a Tube Holder. The summary of testing below using FDA recognized standards shows additional tests conducted to address the differences in length of the needle. Performance testing demonstrated that the differences in length do not raise any questions of safety and effectiveness.
-
- Materials - The subject device includes some different materials in comparison to the predicate device. The biocompatibility and performance testing shows that differences in materials of construction do not raise any questions of safety or effectiveness. The list of test below shows the applicable biocompatibility tests for the Hypotec 001.
- Summary and Conclusion of Nonclinical and Clinical Tests: G.
The SOL-CARE IV Bag Safety Connector met the appropriate requirements contained in thefollowing standards:
-
- EN ISO 7864:2016, Sterile hypodermic needles for single use-Requirements and test methods.
-
- EN ISO 80369-7:2016, Small-bore connectors for liquids and gases in healthcareapplications - Parts for intravascular or hypodermic applications.
-
- EN ISO 9626:2016, Stainless Steel needle tubing for the manufacture of medical devices - Requirements and test methods
-
- ISO 11607-1-2:2017, Packaging for terminally sterilized medical devices, Parts 1 and 2.
-
- ISO 11135:2014, Sterilization of health care products Ethylene oxide -Requirementsfor development, validation and routine control of a sterilization process for medical devices.
-
- ISO 10993-1:2018, Biological evaluation of medical devices Part 1:Evaluation and testing
7
Image /page/7/Picture/0 description: The image shows the logo for SOL-MILLENNIUM. The logo features an orange infinity symbol on the left. To the right of the symbol, the text "SOL-MILLENNIUM" is written in black, with the registered trademark symbol in the upper right corner. Below the company name, the text "Building a healthier tomorrow" is written in a light gray, cursive font.
Summary of Testing:
The tests below are according ISO 7864 except as indicated with the relevant standard adjacent to the testing name.
- Cleanliness o
- Defects of Needle O
- Defects of needle point O
- Lubricant o
- Needle Gauge O
- O Needle Stiffness
- Needle Resistance to Breakage O
- Bond Between Needle hub and Needle O
- Patency of Lumen O
- Distance from Needle tip to Protector Tube O
- Connection Strength Between Protection tube and Needle Hub O
- Penetration Force O
- Luer connection testing per ISO 80369-7 and ISO 80369-20 O
- Flow Rate O
- Priming Volume O
- Particulate Contamination (ISO 8536-4:2019) O
- Limits for acidity or alkalinity (For Needle) O
- Limits of Extractable Metals (For Needle) O
- Needle Resistance to Corrosion ISO 9626:2016 O
- Reducing Substance ISO 8536-4:2010 O
- Metal Ions ISO 8536-4:2010 O
- Titration Acidity or Alkalinity ISO 8536-4:2010 O
- Residue on Evaporation ISO 8536-4:2010 O
- UV Absorption of extract Solution ISO 8536-4:2010 O
Sterilization andPackaging Test according to ISO 11607
- Sterilization (EO/ECH residue) ISO 10993-7 :2008 O
- Appearance (visual check) O
- Dimension (dimensional measurement) O
- Printing (visual check) O
- Tearing Force O
- Clean Peel O
- Dye Penetration O
- UDI Identification O
- Sticker readability and integrity (Visual) O
Biological Test according ISO 10093
- Cytotoxicity (Tested to ISO 10993-5:2009) O
- Sensitization (Tested to ISO 10993-10:2010) O
- Irritation of Intracutaneous Reactivity (Tested to ISO 10993-10:2010) O
- Acute Systemic Toxicity (Tested to ISO 10993-11:2006) O
8
Image /page/8/Picture/0 description: The image shows the logo for SOL-MILLENNIUM. The logo features an abstract orange design on the left, followed by the text "SOL-MILLENNIUM" in black. Below the text, there is a tagline in a cursive font that reads "Building a healthier tomorrow."
- Material Mediated Pyrogenicity (Tested to ISO 10993-11:2006) O
- Hemocompatibility (ISO 10993-4:2017) O
- Partial Thromboplastin (PTT) ISO 10993-4:2017 o
- Platelet Count ISO 10993-4:2017 O
- Haematology ISO 10993-4:2017 O
- H. Discussion of Clinical Tests:
N/A
- I. Conclusions Demonstrating Safety, Effectiveness and Performance:
The differences between the predicate and the subject device do not raise any new or different questions of safety or effectiveness. The proposed devices, SOL-CARE IV Bag Safety Connector have been determined to be substantially equivalent to the predicate device, Inviro Medical Blunt Fill Needle that received marketing clearance on May 15, 2009 under 510(k) number K083851 with respect to the indications for use and technological characteristics.